This editorial describes the science behind clinical trials of an inhibitor of the sodium channel NaV1.8 to treat acute postoperative pain.
No takes yet. Share an insight, caveat, or question.
Stephen G. Waxman (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: